Vanguard S&P 500 ETF (VOO)
506.40
+0.29 (0.06%)
NYSE · Last Trade: Apr 28th, 10:24 AM EDT
The $150 billion investment will include more than $30 billion in research and development to advance and continue IBM's American manufacturing of mainframe and quantum computers.
Via Stocktwits · April 28, 2025
Via The Motley Fool · April 28, 2025
For the full year, Revvity raised its revenue guidance to a range of $2.83 billion to $2.87 billion to reflect recent changes in foreign currency exchange rates.
Via Stocktwits · April 28, 2025
Domino’s reported a 0.5% drop in same-store sales in the U.S. while international same-store sales rose by about 3.7%.
Via Stocktwits · April 28, 2025
Bernstein stated that after high Federal Aviation Administration (FAA) scrutiny, Boeing Commercial Airplanes "should be on a much firmer path than in 2023.”
Via Stocktwits · April 28, 2025
Via The Motley Fool · April 27, 2025
Via The Motley Fool · April 27, 2025
Via The Motley Fool · April 27, 2025
Check out how it compares to an S&P 500 ETF and whether it fits your investing style.
Via The Motley Fool · April 26, 2025
Via The Motley Fool · April 26, 2025
Via The Motley Fool · April 26, 2025
Via The Motley Fool · April 26, 2025
The company now expects the health benefits ratio for the full year to be in the range of 88.9% to 89.5%, up from its previous guidance of 88.4% to 89%.
Via Stocktwits · April 25, 2025
HCA Healthcare now expects full-year adjusted earnings per share of between $24.05 and $25.85, in line with an estimate of $24.96.
Via Stocktwits · April 25, 2025
The company’s immunology drugs, Skyrizi and Rinvoq, marked significant revenue growth, offsetting a 50.6% decrease in net revenue from its arthritis drug, Humira.
Via Stocktwits · April 25, 2025
Revenue increased 16% year-over-year to $4.73 billion but fell short of a Street estimate of $4.86 billion.
Via Stocktwits · April 25, 2025
The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June.
Via Stocktwits · April 25, 2025
According to TheFly, JPMorgan expects continued solid search monetization and artificial intelligence innovation in an uncertain macro environment.
Via Stocktwits · April 25, 2025
Via The Motley Fool · April 25, 2025
United said that the investment includes a path to order up to 100 airplanes and an option for an additional 100.
Via Stocktwits · April 24, 2025
The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85.
Via Stocktwits · April 24, 2025
Revenue for the three months through the end of March rose 8% to $1.29 billion, in line with analyst estimates.
Via Stocktwits · April 24, 2025
Merck estimates that the impact of tariffs implemented to date will result in incremental costs of approximately $200 million.
Via Stocktwits · April 24, 2025
Retail investors are raising concerns over U.S. Treasury Secretary Scott Bessent's recent remarks on tariffs and the ongoing trade tensions with China, delivered at a closed-door investor summit hosted by JPMorgan Chase & Co. (NYSE: JPM).
Via Benzinga · April 23, 2025
Chipotle said Trump’s tariffs might raise its cost of sales by about 0.5% this year, which could translate to tens of millions of dollars in extra spending.
Via Stocktwits · April 23, 2025